Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype - PubMed (original) (raw)

. 1994 Sep 1;54(17):4607-9.

Affiliations

PMID: 8062251

Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype

M E Bracke et al. Cancer Res. 1994.

Abstract

Tamoxifen is an antiestrogen used in adjuvant therapy of breast carcinoma and could potentially prevent the development of mammary cancer. While it is widely clinically used, its exact mechanisms of action are not yet fully elucidated. MCF-7/6 cells are estrogen receptor-positive invasive human breast cancer cells with a functionally inactive cell surface E-cadherin. In this study, we report that tamoxifen, and to a lesser extent its metabolites 4-OH-tamoxifen and N-desmethyltamoxifen, restore the function of E-cadherin in MCF-7/6 cells. In an aggregation assay, 10(-6) M tamoxifen significantly increases the aggregation of MCF-7/6 cells. This effect is abrogated by a monoclonal antibody against E-cadherin (HECD-1), is fast (within 30 min), and does not require de novo protein synthesis. Tamoxifen was also found to inhibit the invasion of MCF-7/6 cells in organ culture. Our data is the first demonstration that tamoxifen can activate the function of an invasion suppressor molecule and suggest that the restoration of E-cadherin function may contribute to the therapeutic benefit of tamoxifen in breast cancer patients.

PubMed Disclaimer

Cited by

Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis.
Welch DR, Steeg PS, Rinker-Schaeffer CW. Welch DR, et al. Breast Cancer Res. 2000;2(6):408-16. doi: 10.1186/bcr87. Epub 2000 Jul 21. Breast Cancer Res. 2000. PMID: 11250734 Free PMC article. Review.
Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid.
Vermeulen SJ, Bruyneel EA, van Roy FM, Mareel MM, Bracke ME. Vermeulen SJ, et al. Br J Cancer. 1995 Dec;72(6):1447-53. doi: 10.1038/bjc.1995.528. Br J Cancer. 1995. PMID: 8519658 Free PMC article.
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.
Cadherin junctions in mammary tumors.
Wheelock MJ, Soler AP, Knudsen KA. Wheelock MJ, et al. J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):275-85. doi: 10.1023/a:1011319507155. J Mammary Gland Biol Neoplasia. 2001. PMID: 11547897 Review.
The role of cadherin-mediated adhesion in breast cancer.
Sommers CL. Sommers CL. J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):219-29. doi: 10.1007/BF02013645. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887495 Review.

Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype - PubMed (original) (raw)